Session

Novel aspects in liver cirrhosis (Posters)

CELL COUNT IN ASCITIC FLUID AS CRITERIA FOR PROPHYLAXIS IN SPONTANEOUS BACTERIAL PERITONITIS
CELL COUNT IN ASCITIC FLUID AS CRITERIA FOR PROPHYLAXIS IN SPONTANEOUS BACTERIAL PERITONITIS

Novel aspects in liver cirrhosis (Posters)  et al.

CLINICAL IMPLICATIONS OF HEPATIC RECOMPENSATION UPON TREATMENT WITH URSODEOXYCHOLIC ACID IN PBC PATIENTS WITH DECOMPENSATED CIRRHOSIS
CLINICAL IMPLICATIONS OF HEPATIC RECOMPENSATION UPON TREATMENT WITH URSODEOXYCHOLIC ACID IN PBC PATIENTS WITH DECOMPENSATED CIRRHOSIS

Novel aspects in liver cirrhosis (Posters)  et al.

BASELINE LIPID METABOLISM DISTURBANCES ARE ASSOCIATED WITH ONSET OF POST-TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT HEPATIC ENCEPHALOPATHY
BASELINE LIPID METABOLISM DISTURBANCES ARE ASSOCIATED WITH ONSET OF POST-TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT HEPATIC ENCEPHALOPATHY

Novel aspects in liver cirrhosis (Posters)  et al.

THE SPLANCHNIC VENOUS THROMBOSIS REGISTRY IN AZIENDA OSPEDALIERO UNIVERSITARIA DELLE MARCHE (SVT-REGISTRY) - DESIGN AND COHORT DESCRIPTION
THE SPLANCHNIC VENOUS THROMBOSIS REGISTRY IN AZIENDA OSPEDALIERO UNIVERSITARIA DELLE MARCHE (SVT-REGISTRY) - DESIGN AND COHORT DESCRIPTION

Novel aspects in liver cirrhosis (Posters)  et al.

THE USE OF STATINS, METFORMIN, AND RAS INHIBITORS DID NOT IMPACT ON VARICEAL BLEEDING RISK AND MORTALITY - A LARGE, REAL-LIFE MULTICENTER STUDY OF PATIENTS WITH CIRRHOSIS
THE USE OF STATINS, METFORMIN, AND RAS INHIBITORS DID NOT IMPACT ON VARICEAL BLEEDING RISK AND MORTALITY - A LARGE, REAL-LIFE MULTICENTER STUDY OF PATIENTS WITH CIRRHOSIS

Novel aspects in liver cirrhosis (Posters)  et al.

LACTOFERRIN VERSUS CALPROTECTIN – NOVEL PROGNOSTIC AND PREDICTIVE MARKERS FOR EARLY DIAGNOSIS OF SPONTANEOUS BACTERIAL PERITONITIS IN PATIENTS WITH LIVER CIRRHOSIS
LACTOFERRIN VERSUS CALPROTECTIN – NOVEL PROGNOSTIC AND PREDICTIVE MARKERS FOR EARLY DIAGNOSIS OF SPONTANEOUS BACTERIAL PERITONITIS IN PATIENTS WITH LIVER CIRRHOSIS

Novel aspects in liver cirrhosis (Posters)  et al.

INCIDENCE OF THROMBOSIS IN BRANCHES OF THE PORTAL VEIN AND ITS IMPACT ON LIVER FUNCTION AMONG DECOMPENSATED CIRRHOSIS PATIENTS RECEIVING TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT: A PROSPECTIVE NESTED CASE‒CONTROL STUDY
INCIDENCE OF THROMBOSIS IN BRANCHES OF THE PORTAL VEIN AND ITS IMPACT ON LIVER FUNCTION AMONG DECOMPENSATED CIRRHOSIS PATIENTS RECEIVING TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT: A PROSPECTIVE NESTED CASE‒CONTROL STUDY

Novel aspects in liver cirrhosis (Posters)  et al.

THE HEPATIC VENOUS PRESSURE GRADIENT (HVPG) SCORE AS PREDICTOR TOOL OF BLEEDING IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
THE HEPATIC VENOUS PRESSURE GRADIENT (HVPG) SCORE AS PREDICTOR TOOL OF BLEEDING IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Novel aspects in liver cirrhosis (Posters)  et al.

THE RISKS OF FIRST HEPATIC DECOMPENSATION AND HCC REMAIN CONSTANT DURING LONG-TERM FOLLOW-UP AND CAN BE STRATIFIED BY A ONE-TIME ASSESSMENT AFTER HCV-CURE
THE RISKS OF FIRST HEPATIC DECOMPENSATION AND HCC REMAIN CONSTANT DURING LONG-TERM FOLLOW-UP AND CAN BE STRATIFIED BY A ONE-TIME ASSESSMENT AFTER HCV-CURE

Novel aspects in liver cirrhosis (Posters)  et al.

THE RISKS OF FIRST HEPATIC DECOMPENSATION AND HCC REMAIN CONSTANT DURING LONG-TERM FOLLOW-UP AND CAN BE STRATIFIED BY A ONE-TIME ASSESSMENT AFTER HCV-CURE
THE RISKS OF FIRST HEPATIC DECOMPENSATION AND HCC REMAIN CONSTANT DURING LONG-TERM FOLLOW-UP AND CAN BE STRATIFIED BY A ONE-TIME ASSESSMENT AFTER HCV-CURE

CLINICAL IMPLICATIONS OF HEPATIC RECOMPENSATION UPON TREATMENT WITH URSODEOXYCHOLIC ACID IN PBC PATIENTS WITH DECOMPENSATED CIRRHOSIS
CLINICAL IMPLICATIONS OF HEPATIC RECOMPENSATION UPON TREATMENT WITH URSODEOXYCHOLIC ACID IN PBC PATIENTS WITH DECOMPENSATED CIRRHOSIS

THE SPLANCHNIC VENOUS THROMBOSIS REGISTRY IN AZIENDA OSPEDALIERO UNIVERSITARIA DELLE MARCHE (SVT-REGISTRY) - DESIGN AND COHORT DESCRIPTION
THE SPLANCHNIC VENOUS THROMBOSIS REGISTRY IN AZIENDA OSPEDALIERO UNIVERSITARIA DELLE MARCHE (SVT-REGISTRY) - DESIGN AND COHORT DESCRIPTION

THE USE OF STATINS, METFORMIN, AND RAS INHIBITORS DID NOT IMPACT ON VARICEAL BLEEDING RISK AND MORTALITY - A LARGE, REAL-LIFE MULTICENTER STUDY OF PATIENTS WITH CIRRHOSIS
THE USE OF STATINS, METFORMIN, AND RAS INHIBITORS DID NOT IMPACT ON VARICEAL BLEEDING RISK AND MORTALITY - A LARGE, REAL-LIFE MULTICENTER STUDY OF PATIENTS WITH CIRRHOSIS

LACTOFERRIN VERSUS CALPROTECTIN – NOVEL PROGNOSTIC AND PREDICTIVE MARKERS FOR EARLY DIAGNOSIS OF SPONTANEOUS BACTERIAL PERITONITIS IN PATIENTS WITH LIVER CIRRHOSIS
LACTOFERRIN VERSUS CALPROTECTIN – NOVEL PROGNOSTIC AND PREDICTIVE MARKERS FOR EARLY DIAGNOSIS OF SPONTANEOUS BACTERIAL PERITONITIS IN PATIENTS WITH LIVER CIRRHOSIS

THE HEPATIC VENOUS PRESSURE GRADIENT (HVPG) SCORE AS PREDICTOR TOOL OF BLEEDING IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
THE HEPATIC VENOUS PRESSURE GRADIENT (HVPG) SCORE AS PREDICTOR TOOL OF BLEEDING IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

CELL COUNT IN ASCITIC FLUID AS CRITERIA FOR PROPHYLAXIS IN SPONTANEOUS BACTERIAL PERITONITIS
CELL COUNT IN ASCITIC FLUID AS CRITERIA FOR PROPHYLAXIS IN SPONTANEOUS BACTERIAL PERITONITIS

BASELINE LIPID METABOLISM DISTURBANCES ARE ASSOCIATED WITH ONSET OF POST-TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT HEPATIC ENCEPHALOPATHY
BASELINE LIPID METABOLISM DISTURBANCES ARE ASSOCIATED WITH ONSET OF POST-TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT HEPATIC ENCEPHALOPATHY

INCIDENCE OF THROMBOSIS IN BRANCHES OF THE PORTAL VEIN AND ITS IMPACT ON LIVER FUNCTION AMONG DECOMPENSATED CIRRHOSIS PATIENTS RECEIVING TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT: A PROSPECTIVE NESTED CASE‒CONTROL STUDY
INCIDENCE OF THROMBOSIS IN BRANCHES OF THE PORTAL VEIN AND ITS IMPACT ON LIVER FUNCTION AMONG DECOMPENSATED CIRRHOSIS PATIENTS RECEIVING TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT: A PROSPECTIVE NESTED CASE‒CONTROL STUDY

Item 1 - 18 / 18
1